Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Dalgard

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|January 31, 2004
Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infectionOlav Dalgard, Atle Egeland, Kjell Skaug, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2002
[Treatment of chronic hepatitis C]Helge Bell, Olav Dalgard, Kristian Bjøro, et al.
Open Forum Infectious Diseases|June 26, 2025
Empiric Antibiotic Therapy in Suspected Sepsis: Impact of Gentamicin-Based Regimens on Incident Renal Failure and MortalityMagrit Jarlsdatter Hovind, Jan Erik Berdal, Olav Dalgard, et al.
Infectious Diseases (London, England)|July 8, 2025
Time from migration to diagnosis and the proportion presenting late among diagnosed cases of chronic hepatitis B in Norway, 2008 to 2022Beatriz Valcarcel Salamanca, Asgeir Johannessen, Olav Dalgard, et al.
Plos One|November 16, 2016
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based StudyHåvard Midgard, Jørgen G Bramness, Svetlana Skurtveit, et al.
The International Journal on Drug Policy|May 4, 2024
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral eraCaroline Gahrton, Georg Navér, Anna Warnqvist, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2009
[Risk factors for hepatitis C among injecting drug users in Oslo]Olav Dalgard, Atle Egeland, Randi Ervik, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 3, 2015
Hepatitis C treatment at three Norwegian hospitals 2000-2011Kjetil Isaksen, Lars Aabakken, Tore Grimstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 4, 2008
[Hepatitis C--a health problem also in Norway]Inger Sofie Samdal Vik, Kjell Skaug, Olav Dalgard, et al.
Journal of Advanced Nursing|October 31, 2017
Increased hope following successful treatment for hepatitis C infectionBenedikte Bjøro, Olav Dalgard, Håvard Midgard, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|January 31, 2004
Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infectionOlav Dalgard, Atle Egeland, Kjell Skaug, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2002
[Treatment of chronic hepatitis C]Helge Bell, Olav Dalgard, Kristian Bjøro, et al.
Open Forum Infectious Diseases|June 26, 2025
Empiric Antibiotic Therapy in Suspected Sepsis: Impact of Gentamicin-Based Regimens on Incident Renal Failure and MortalityMagrit Jarlsdatter Hovind, Jan Erik Berdal, Olav Dalgard, et al.
Infectious Diseases (London, England)|July 8, 2025
Time from migration to diagnosis and the proportion presenting late among diagnosed cases of chronic hepatitis B in Norway, 2008 to 2022Beatriz Valcarcel Salamanca, Asgeir Johannessen, Olav Dalgard, et al.
Plos One|November 16, 2016
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based StudyHåvard Midgard, Jørgen G Bramness, Svetlana Skurtveit, et al.
The International Journal on Drug Policy|May 4, 2024
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral eraCaroline Gahrton, Georg Navér, Anna Warnqvist, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2009
[Risk factors for hepatitis C among injecting drug users in Oslo]Olav Dalgard, Atle Egeland, Randi Ervik, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 3, 2015
Hepatitis C treatment at three Norwegian hospitals 2000-2011Kjetil Isaksen, Lars Aabakken, Tore Grimstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 4, 2008
[Hepatitis C--a health problem also in Norway]Inger Sofie Samdal Vik, Kjell Skaug, Olav Dalgard, et al.
Journal of Advanced Nursing|October 31, 2017
Increased hope following successful treatment for hepatitis C infectionBenedikte Bjøro, Olav Dalgard, Håvard Midgard, et al.
Pageof 11